Related Experiment Video
Updated: Apr 24, 2026

Mouse Body Temperature Measurement Using Infrared Thermometer During Passive Systemic Anaphylaxis and Food Allergy Evaluation
Published on: September 14, 2018
Neffy: A latest needle-free epinephrine
Konica Chittoria1, Arun Mukesh2, Ankur Sharma3
1Department of Anesthesiology and Critical Care, AIIMS, Jodhpur, Rajasthan, India.
Neffy, a needle-free nasal epinephrine spray, offers a promising alternative for anaphylaxis treatment. It addresses limitations of autoinjectors, potentially improving emergency allergy care.
Area of Science:
- Allergy and Immunology
- Pharmacology
- Emergency Medicine
Background:
- Anaphylaxis is a severe allergic reaction requiring immediate epinephrine.
- Epinephrine autoinjectors are standard but face challenges like needle phobia and usability issues.
- Neffy (epinephrine nasal spray) presents a novel needle-free delivery method.
Purpose of the Study:
- To review the clinical evidence for Neffy.
- To examine its pharmacological profile, indications, and safety.
- To discuss Neffy's impact on clinical practice for anaphylaxis management.
Main Methods:
- Literature review of clinical studies on Neffy.
- Analysis of pharmacological data and safety profiles.
- Discussion of clinical practice implications.
Main Results:
- Neffy provides intranasal epinephrine delivery, bypassing needles.
- The review covers efficacy, safety, and patient-reported outcomes.
- Neffy demonstrates potential to overcome autoinjector limitations.
Conclusions:
- Neffy offers a viable needle-free option for emergency anaphylaxis treatment.
- It may improve treatment adherence and accessibility.
- Further research and clinical integration are warranted.
Related Concept Videos
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Drug Delivery: Enteral Route
Allergic Reactions
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Cardiopulmonary Resuscitation IV: Pharmacological Management

